232 related articles for article (PubMed ID: 18813360)
21. Accuracy of clinical examination, digital mammogram, ultrasound, and MRI in determining postneoadjuvant pathologic tumor response in operable breast cancer patients.
Croshaw R; Shapiro-Wright H; Svensson E; Erb K; Julian T
Ann Surg Oncol; 2011 Oct; 18(11):3160-3. PubMed ID: 21947594
[TBL] [Abstract][Full Text] [Related]
22. US-guided implantation of metallic markers for permanent localization of the tumor bed in patients with breast cancer who undergo preoperative chemotherapy.
Edeiken BS; Fornage BD; Bedi DG; Singletary SE; Ibrahim NK; Strom EA; Holmes F
Radiology; 1999 Dec; 213(3):895-900. PubMed ID: 10580972
[TBL] [Abstract][Full Text] [Related]
23. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
24. Utility of initial MRI for predicting extent of residual disease after neoadjuvant chemotherapy: analysis of 70 breast cancer patients.
Murata Y; Ogawa Y; Yoshida S; Kubota K; Itoh S; Fukumoto M; Nishioka A; Moriki T; Maeda H; Tanaka Y
Oncol Rep; 2004 Dec; 12(6):1257-62. PubMed ID: 15547747
[TBL] [Abstract][Full Text] [Related]
25. [Importance of mammography, sonography and MRI for surveillance of neoadjuvant chemotherapy for locally advanced breast cancer].
Schlossbauer T; Reiser M; Hellerhoff K
Radiologe; 2010 Nov; 50(11):1008-13. PubMed ID: 20922360
[TBL] [Abstract][Full Text] [Related]
26. Residual microcalcifications after neoadjuvant chemotherapy for locally advanced breast cancer: comparison of the accuracies of mammography and MRI in predicting pathological residual tumor.
An YY; Kim SH; Kang BJ
World J Surg Oncol; 2017 Nov; 15(1):198. PubMed ID: 29110671
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of preoperative chemotherapy using PET with fluorine-18-fluorodeoxyglucose in breast cancer.
Bassa P; Kim EE; Inoue T; Wong FC; Korkmaz M; Yang DJ; Wong WH; Hicks KW; Buzdar AU; Podoloff DA
J Nucl Med; 1996 Jun; 37(6):931-8. PubMed ID: 8683314
[TBL] [Abstract][Full Text] [Related]
28. 18 F-fluorodeoxyglucose uptake predicts pathological complete response after neoadjuvant chemotherapy for breast cancer: a retrospective cohort study.
Jin S; Kim SB; Ahn JH; Jung KH; Ahn SH; Son BH; Lee JW; Gong G; Kim HO; Moon DH
J Surg Oncol; 2013 Feb; 107(2):180-7. PubMed ID: 22948739
[TBL] [Abstract][Full Text] [Related]
29. Early prediction of pathologic response to neoadjuvant therapy in breast cancer: systematic review of the accuracy of MRI.
Marinovich ML; Sardanelli F; Ciatto S; Mamounas E; Brennan M; Macaskill P; Irwig L; von Minckwitz G; Houssami N
Breast; 2012 Oct; 21(5):669-77. PubMed ID: 22863284
[TBL] [Abstract][Full Text] [Related]
30. Sentinel lymph node biopsy in patients with operable breast cancer treated with neoadjuvant chemotherapy.
Rebollo-Aguirre AC; Gallego-Peinado M; Menjón-Beltrán S; García-García J; Pastor-Pons E; Chamorro-Santos CE; Ramos-Font C; Salamanca-Ballesteros A; Llamas-Elvira JM; Olea-Serrano N
Rev Esp Med Nucl Imagen Mol; 2012; 31(3):117-23. PubMed ID: 21676504
[TBL] [Abstract][Full Text] [Related]
31. Assessing residual cancer cells using MRI and US after preoperative chemotherapy in primary breast cancer to omit surgery.
Iwase M; Sawaki M; Hattori M; Yoshimura A; Ishiguro J; Kotani H; Gondo N; Adachi Y; Kataoka A; Onishi S; Sugino K; Iwata H
Breast Cancer; 2018 Sep; 25(5):583-589. PubMed ID: 29619758
[TBL] [Abstract][Full Text] [Related]
32. Accuracy of the combination of mammography and sonography in predicting tumor response in breast cancer patients after neoadjuvant chemotherapy.
Peintinger F; Kuerer HM; Anderson K; Boughey JC; Meric-Bernstam F; Singletary SE; Hunt KK; Whitman GJ; Stephens T; Buzdar AU; Green MC; Symmans WF
Ann Surg Oncol; 2006 Nov; 13(11):1443-9. PubMed ID: 17028770
[TBL] [Abstract][Full Text] [Related]
33. Predictive value of axillary nodal imaging by magnetic resonance imaging based on breast cancer subtype after neoadjuvant chemotherapy.
Steiman J; Soran A; McAuliffe P; Diego E; Bonaventura M; Johnson R; Ahrendt G; McGuire K
J Surg Res; 2016 Jul; 204(1):237-41. PubMed ID: 27451892
[TBL] [Abstract][Full Text] [Related]
34. Near-Infrared Diffuse Optical Imaging for Early Prediction of Breast Cancer Response to Neoadjuvant Chemotherapy: A Comparative Study Using 18F-FDG PET/CT.
Ueda S; Yoshizawa N; Shigekawa T; Takeuchi H; Ogura H; Osaki A; Saeki T; Ueda Y; Yamane T; Kuji I; Sakahara H
J Nucl Med; 2016 Aug; 57(8):1189-95. PubMed ID: 26940765
[TBL] [Abstract][Full Text] [Related]
35. Ultrasound is at least as good as magnetic resonance imaging in predicting tumour size post-neoadjuvant chemotherapy in breast cancer.
Vriens BE; de Vries B; Lobbes MB; van Gastel SM; van den Berkmortel FW; Smilde TJ; van Warmerdam LJ; de Boer M; van Spronsen DJ; Smidt ML; Peer PG; Aarts MJ; Tjan-Heijnen VC;
Eur J Cancer; 2016 Jan; 52():67-76. PubMed ID: 26650831
[TBL] [Abstract][Full Text] [Related]
36. MRI staging after neoadjuvant chemotherapy for breast cancer: does tumor biology affect accuracy?
McGuire KP; Toro-Burguete J; Dang H; Young J; Soran A; Zuley M; Bhargava R; Bonaventura M; Johnson R; Ahrendt G
Ann Surg Oncol; 2011 Oct; 18(11):3149-54. PubMed ID: 21947592
[TBL] [Abstract][Full Text] [Related]
37. [Value of dynamic contrast-enhanced MRI in assessment of early response to neoadjuvant chemotherapy in breast cancer].
Wang XH; Peng WJ; Xin C; Tan HN; Gu YJ; Tang F; Mao J
Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):539-43. PubMed ID: 21029700
[TBL] [Abstract][Full Text] [Related]
38. Monitoring the response to primary medical therapy for breast cancer using three- dimensional time-resolved optical mammography.
Enfield LC; Cantanhede G; Westbroek D; Douek M; Purushotham AD; Hebden JC; Gibson AP
Technol Cancer Res Treat; 2011 Dec; 10(6):533-47. PubMed ID: 22066594
[TBL] [Abstract][Full Text] [Related]
39. Role of dynamic magnetic resonance imaging in the evaluation of tumor response to preoperative concurrent radiochemotherapy for large breast cancers: a prospective phase II study.
Bollet MA; Thibault F; Bouillon K; Meunier M; Sigal-Zafrani B; Savignoni A; Diéras V; Nos C; Salmon R; Fourquet A;
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):13-8. PubMed ID: 17449193
[TBL] [Abstract][Full Text] [Related]
40. Contrast enhanced ultrasound of breast cancer.
Cassano E; Rizzo S; Bozzini A; Menna S; Bellomi M
Cancer Imaging; 2006 Jan; 6(1):4-6. PubMed ID: 16478698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
